Develop a circular RNA-related regulatory network associated with prognosis of gastric cancer
- PMID: 32902196
- PMCID: PMC7666747
- DOI: 10.1002/cam4.3035
Develop a circular RNA-related regulatory network associated with prognosis of gastric cancer
Abstract
Background: In gastric cancer (GC), circular RNAs (circRNAs) mainly play an important role in miRNA sponge, which not only indicate long-term survival and prognosis but also increase resistance to the apoptosis. The purpose of the study is to explore new circRNAs and their underlying mechanisms in GC.
Method: Through rigorous retrieval strategies, we used the sva package to analyze and identify differentially expressed circRNAs (DECs) from three Gene Expression Omnibus microarray datasets (GSE83521, GSE89143, and GSE78092). Online website CSCD and CircInteractome were used to reveal the binding sites between miRNAs and DECs. The possible target miRNAs of the DECs identified based on miRNAs, and Cytoscape was used to create a regulatory network of circRNA-miRNA-mRNA and identified the hub genes which were further validated using The Cancer Genome Atlas database and Human Protein Atlas.
Results: Twenty-eight DECs were obtained using the sva package. A regulatory network of circRNA-miRNA-mRNA (competing endogenous RNA) containing 15 circRNAs, 24 miRNAs, and 158 genes was identified. A protein-protein interaction network based on the 158 genes was established, and further determined that 10 hub genes (SKA1, ANLN, CHEK1, SKA3, TOP2A, BIRC5, RRM2, NCAPG2, FANCI, and RAD51) were associated with some cancer-related pathways based on the functional enrichment analysis. Finally, six hub genes (BIRC5, TOP2A, FANCI, NCAPG2, RAD51, and RRM2) were proven to influence the overall survival of GC.
Conclusion: Our study established a circRNA-miRNA-mRNA regulatory network and defined six circRNA-related hub genes in GC, which could serve as potential therapeutic targets or prognostic biomarker for GC treatment.
Keywords: ceRNA; circRNA; gastric cancer; prognosis; regulatory network.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Russo AE, Strong VE. Gastric cancer etiology and management in Asia and the West. Annu Rev Med. 2019;70:353‐367. - PubMed
-
- Ilson DH. Advances in the treatment of gastric cancer. Curr Opin Gastroenterol. 2018;34(6):465‐468. - PubMed
-
- Tanzer M, Liebl M, Quante M. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma. Pharmacol Ther. 2013;140(2):133‐147. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
